facebook
twitter
rss
account
search
search
 

Wyeth's Prevnar sales booming

Nov. 4, 2004 at 1:10 PM   |   Comments

CHICAGO, Nov. 4 (UPI) -- Prevnar, the popular drug to prevent bacterial meningitis, is on course to make more than $1 billion this year, a report says.

Sales of Prevnar, made by the pharmaceutical giant Wyeth, soared 32 percent in the third quarter to $321 million, the Chicago Tribune said Thursday.

A recent financial statement indicated this came about in part because the company made upgrades and improvements to its manufacturing facilities over the last year.

Prevnar vaccine costs about $260 for the four-shot regimen given to infants and young children. A dose of flu vaccine, by contrast, fetches about $8.

Wyeth left the flu vaccine market entirely last year to focus resources on its more lucrative vaccine.

© 2004 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Russian bank boss feeling sanctions pain Russian bank boss feeling sanctions pain
2
Army deploying JLENS radar system to help protect Washington, D.C. Army deploying JLENS radar system to help protect Washington, D.C.
3
Navy's Triton surveillance drone flies cross-country Navy's Triton surveillance drone flies cross-country
4
EIA: Russia diversifying energy production EIA: Russia diversifying energy production
5
New GenDyn mission computers for Navy F/A-18s New GenDyn mission computers for Navy F/A-18s
Trending News
Video
x
Feedback